Course 5: T.A.T S.E.T The Map Trading System
Course 5: T.A.T S.E.T The Map Trading System
Source link
Similar Posts
Stock market update: Mining stocks down as market falls
NEW DELHI: Mining shares closed lower in the Wednesday’s session. Lexus Granito(India)Ltd.(up 2.12%), Ashapura Minechem Ltd.(up 1.70%) and Oriental Trimex Ltd.(up 1.18%) stood among the top gainers. The Orissa Minerals Development Company Ltd.(down 2.01%), Madhav Marbles & Granites Ltd.(down 1.80%), 20 Microns Ltd.(down 1.70%), Pokarna Ltd.(down 1.62%), Gujarat Mineral Development Corporation Ltd.(down 1.08%), Sandur Manganese…
India to Seek Cabinet Nod for Rs 32,000–35,000 Cr LPG Loss Reimbursement to OMCs
July 10, 2025July 10, 2025 The central government is planning to seek Cabinet approval for a compensation package worth Rs 32,000–35,000 crore to reimburse oil marketing companies (OMCs) for losses from selling subsidised LPG in the current financial year, according to senior government officials. This financial support is intended…
VantagePoint A.I. Stock of the Week Canadian Natural Resources Ltd. ($CNQ) – VantagePoint $CNQ
The A.I. stock spotlight this week is Canadian Natural Resources Ltd. ($CNQ) Canadian Natural Resources didn’t exactly spring from the ground like oil itself, but it might as well have. Founded in the late 1980s when energy was less fashionable than disco, it grew from a modest exploration outfit into a sprawling hydrocarbon empire, survived multiple oil…
The TFSA Number You Need to Hit Before Calling it Quits
If you’re a Canadian investor eyeing retirement, one question may keep soon-to-be retirees up at night: What’s the magic Tax-Free Savings Account (TFSA) number you need to hit before hanging up your work boots? The TFSA isn’t just a handy savings bucket. It’s a tax-free growth machine that can supercharge your nest egg. With cumulative…
Renaissance Technologies LLC Has $1.29 Million Stock Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
Renaissance Technologies LLC reduced its stake in shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 63.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 496,200 shares of the company’s stock after selling 879,600 shares during the pe Source link
